All News

The FDA approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes (T2D). It's the first SGLT2 inhibitor to gain this approval in what is expected to be the next front of competition in this game-changing drug class.

Levels of caffeine consumption and lower blood urate were both inversely associated with the risk of Parkinson disease, highlighting the benefit derived from sufficient levels of both components, according to study findings.

Investigators hope that an experimental test could detect the novel coronavirus at a much lower cost than current tests; the FDA has extended the action date for a chimeric antigen receptor (CAR) T-cell therapy application from Bristol Myers Squibb (BMS); engineering teams devise inexpensive ventilators for emergency use.

As the coronavirus disease 2019 pandemic causes employers nationwide to implement strategies to efficiently operate amid potential revenue loss, the National Alliance of Healthcare Purchaser Coalitions released a comprehensive plan for employers and plan sponsors to optimize the delivery of advanced primary care.

A new test, supported by an artificial intelligence (AI) algorithm, can detect glaucoma progression a year and a half earlier than widely used optical coherence tomography retinal imaging technology, according to a study published in Expert Review of Molecular Diagnostics.

More than 26 million individuals worldwide live with heart failure every day. Because the condition is irreversible, finding ways and treatments to remedy this damage has long been a goal of physician-researchers.

New research suggests disparities in incidence and survival rates in multiple myeloma may have a lot to do with healthcare quality and access to care.

After first relaxing regulations that let them enter the market, the FDA will now require companies manufacturing antibody tests for the coronavirus disease 2019 (COVID-19) to submit data on their efficacy; Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases, said that current research indicates that COVID-19 evolved naturally; a novel COVID-19 mortality model predicts nearly double its initially projected death toll after factoring in some states beginning to ease social distancing restrictions and allowing businesses to reopen.

Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations.

African Americans with severe sleep apnea are more likely to have higher blood glucose levels, according to a new study published in the Journal of the American Heart Association. High blood glucose levels increase the risk of developing diabetes, a disease already more prevalent in African Americans.

Although men with moderate lifetime alcohol consumption were at higher risk of developing Parkinson disease (PD) compared with light drinkers, no significant link was found between alcohol consumption and risk of PD, according to study findings.

Restrictions on the sale and marketing of e-cigarettes containing nicotine are less strict in Canada and the United States compared with England.

Northeastern states formed a consortium to purchase personal protective equipment and other supplies to cope with coronavirus disease 2019 (COVID-19); the pandemic highlights public health identitity crisis; President Trump revises US pandemic death toll.

A 2017 paper that examined the links between insurance type and delays in care brought some interesting results.

Clinicians treating patients with multiple myeloma have a number of factors to consider as they treat patients in an era of high-risk COVID-19 infection.

The evolution of cancer treatment towards a precision-based approach has led to significant progress in cancer therapy. However, some challenges do arise when shifting from an organ-centric concept, guiding treatment choices to a more personalized approach, according to a review published in Cancers.

Widespread testing targeted at the most vulnerable communities at risk of suffering complications from the coronavirus disease 2019 (COVID-19) is imperative to successfully managing this pandemic, said Tracey Brown, chief executive officer of the American Diabetes Association.

Patient survival following acute exacerbation depended on the pulmonary fibrosis type of the patient, according to the paper.

In Europe, the authors of this new study suggest, some patent barriers may be more illusory than real.

New research could make it easier to find out which patients are mostly likely to go on to develop multiple myeloma. The findings could have implications for therapeutic interventions.

The FDA announced today it will grant emergency use authorization to Gilead Sciences' remdesivir, a drug that showed early promise in treating coronavirus disease 2019 (COVID-19).

In recent years, targeted cancer therapies have increased in use. These individualized treatments are based on the genetic makeup of a patient's disease.

There is a 15% to 20% greater chance of death in the 90 days following a hospitalization for heart failure among patients with Medicare compared with the general population. Social determinants of health (SDOH) are an influencing factor of this rate.

Those who lived alone had more risk for respiratory disease hospitalization compared with those who did not, the study authors said.

Florida Cancer Specialists will pay $100 million as a criminal penalty for antitrust violations; CMS will exclude spending associated with the coronavirus disease 2019 pandemic from accountable care organization (ACO) performance calculations; the Department of Veterans Affairs orders $300,000 worth of body bags.

Chronic lymphocytic leukemia/small cell lymphoma (CLL/SLL) is rare, making it difficult to differentiate from other types of lymphoma. A new study helps explain key unique traits.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The Supreme Court says insurers are owed $12 billion under the Affordable Care Act; a study finds those with cancer are at higher risk from coronavirus disease 2019 (COVID-19); a survey shows millions would avoid seeking care for COVID-19 due to cost.